The effects of N-acetylcysteine on experimentally created l-asparaginase-induced liver and pancreatic damage in rats

References

• Jabbour EJ, Faderl S, Kantarjian HM. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2005;80(11):1517–1527.
   PubMed Web of Science ®Google Scholar
• Schmiegelow K, Glomstein A, Kristinsson J, et al. Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO). J Pediatr Hematol Oncol. 1997;19:102–110.
   PubMed Web of Science ®Google Scholar
• Offman MN, Krol M, Patel N, et al. Rational engineering of l-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood. 2011;117(5):1614–1621.
   PubMed Web of Science ®Google Scholar
• LiverTox. Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547852/
   Google Scholar
• Kamal N, Koh C, Samala N, et al. Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis. Hepatol Int. 2019;13(5):641–648.
   PubMed Web of Science ®Google Scholar
• Alvarez OA, Zimmerman G. Pegaspargase-induced pancreatitis. Med Pediatr Oncol. 2000;34(3):200–205.
   PubMedGoogle Scholar
• Hijiya N, van der Sluis IM. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2016;57(4):748–757.
   PubMed Web of Science ®Google Scholar
• Sahu S, Saika S, Pai SK, et al. l-Asparaginase (leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1998;15(6):533–538.
   PubMed Web of Science ®Google Scholar
• Wolthers BO, Frandsen TL, Baruchel A, et al. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study. Lancet Oncol. 2017;18(9):1238–1248.
   PubMed Web of Science ®Google Scholar
• Garrington T, Bensard D, Ingram JD, et al. Successful management with octreotide of a child with l-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol. 1998;30(2):106–109.
   PubMedGoogle Scholar
• Knoderer HM, Robarge J, Flockhart DA. Predicting asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2007;49(5):634–639.
   PubMed Web of Science ®Google Scholar
• Wu SF, Chen AC, Peng CT, et al. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51(6):824–825.
   PubMed Web of Science ®Google Scholar
• Cheuk DK, Sieswerda E, van Dalen EC, et al. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst Rev. 2016;23:CD008011.
   Google Scholar
• Bartlett JJ, Trivedi PC, Yeung P, et al. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy. Biochem J. 2016;473(21):3769–3789.
   PubMed Web of Science ®Google Scholar
• Piegari E, Russo R, Cappetta D, et al. MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat. Oncotarget. 2016;7(38):62312–62326.
   PubMedGoogle Scholar
• Vrooman LM, Supko JG, Neuberg DS, et al. Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;54(2):199–205.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Suzuki HI, Fujimura T, et al. A clinically attainable dose of l-asparaginase targets glutamine addiction in lymphoid cell lines. Cancer Sci. 2015;106(11):1534–1543.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Shimizu T, Kudo T, et al. Octreotide prevents l-asparaginase-induced pancreatic injury in rats. Exp Hematol. 2008;36(2):172–180.
   PubMed Web of Science ®Google Scholar
• Issels RD, Nagele A, Eckert KG, et al. Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem Pharmacol. 1988;37(5):881–888.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358.
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Beutler E. Accurate measurement of oxidized glutathione content of human, rabbit, and rat red blood cells and tissues. Anal Biochem. 1968;25(1):70–76.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.
   PubMed Web of Science ®Google Scholar
• Kaya I, Citil M, Sozmen M, et al. Investigation of protective effect of l-carnitine on l-asparaginase-induced acute pancreatic injury in male Balb/c mice. Dig Dis Sci. 2015;60(5):1290–1296.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29(3):313–324.
   PubMed Web of Science ®Google Scholar
• Liao J, Liu PP, Hou G, et al. Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling. Mol Cancer. 2017;16(1):51.
   PubMed Web of Science ®Google Scholar
• Alachkar H, Fulton N, Sanford B, et al. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. Pharmacogenomics J. 2017;17(3):274–279.
   PubMed Web of Science ®Google Scholar
• Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012;52(1):59–69.
   PubMed Web of Science ®Google Scholar
• Ribeiro G, Roehrs M, Bairros A, et al. N-acetylcysteine on oxidative damage in diabetic rats. Drug Chem Toxicol. 2011;34(4):467–474.
   PubMed Web of Science ®Google Scholar
• Raza M, Ahmad M, Gado A, et al. A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine. Comp Biochem Physiol C Toxicol Pharmacol. 2003;134(4):451–456.
   PubMed Web of Science ®Google Scholar
• Kaya H, Koc A, Sogut S, et al. The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats. J Appl Toxicol. 2008;28(1):15–20.
   PubMed Web of Science ®Google Scholar
• Akbulut S, Elbe H, Eris C, et al. Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. World J Gastroenterol. 2014;20(29):10158–10165.
   PubMed Web of Science ®Google Scholar
• Kawashima K, Takeshima H, Higashi Y, et al. High efficacy of monomethoxypolyethylene glycol-conjugated l-asparaginase (PEG2-ASP) in two patients with hematological malignancies. Leuk Res. 1991;15(6):525–530.
   PubMed Web of Science ®Google Scholar
• Ramudo L, Manso M. N-acetylcysteine in acute pancreatitis. World J Gastrointest Pharmacol Ther. 2010;1(1):21–26.
   PubMedGoogle Scholar
• Trang E, Ngo D, Chen J, et al. Levocarnitine for pegasparaginase-induced hepatotoxicity in acute lymphoblastic leukemia. Leuk Lymphoma. 2020;61(13):3161–3164.
   PubMed Web of Science ®Google Scholar
• Alshiekh-Nasany R, Douer D. l-Carnitine for treatment of pegasparaginase-induced hepatotoxicity. Acta Haematol. 2016;135(4):208–210.
   PubMed Web of Science ®Google Scholar
• Lee C, Leventhal TM, Anugwom CM. l-Asparaginase-induced hepatotoxicity treated successfully with l-carnitine and vitamin B infusion. Cureus. 2021;13(8):e16917.
   PubMed Web of Science ®Google Scholar
• Al-Nawakil C, Willems L, Mauprivez C, et al. Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors. Leuk Lymphoma. 2014;55(7):1670–1674.
   PubMed Web of Science ®Google Scholar
• Blackman A, Boutin A, Shimanovsky A, et al. Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: a case report and review of the literature. J Oncol Pharm Pract. 2018;24(5):393–397.
   PubMed Web of Science ®Google Scholar
• Özdemir ZC, Turhan AB, Eren M, et al. Is N-acetylcysteine infusion an effective treatment option in l-asparaginase associated hepatotoxicity? Blood Res. 2017;52(1):69–71.
   PubMed Web of Science ®Google Scholar
• Harrison PM, Wendon JA, Gimson AE, et al. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324(26):1852–1857.
   PubMed Web of Science ®Google Scholar
• Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026–1029.
   PubMed Web of Science ®Google Scholar
• Sevillano S, de la Mano AM, Manso MA, et al. N-acetylcysteine prevents intra-acinar oxygen free radical production in pancreatic duct obstruction-induced acute pancreatitis. Biochim Biophys Acta. 2003;1639(3):177–184.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Inoue J, Sakaguchi K, et al. Autophagy is required for cell survival under l-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells. Oncogene. 2017;36(30):4267–4276.
   PubMed Web of Science ®Google Scholar
• Muldoon LL, Wu YJ, Pagel MA, et al. N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models. J Neurooncol. 2015;121(3):433–440.
   PubMed Web of Science ®Google Scholar
• Hanly L, Figueredo R, Rieder MJ, et al. The effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model. Anticancer Res. 2012;32:3791–3798.
   PubMed Web of Science ®Google Scholar